» Articles » PMID: 35877201

Selective Cell Size MRI Differentiates Brain Tumors from Radiation Necrosis

Abstract

Significance: This work introduces and provides preclinical validation of a new diffusion MRI method that exploits intrinsic differences in cell sizes to distinguish brain tumors and radiotherapy necrosis.

Citing Articles

Assessing tumor microstructure with time-dependent diffusion imaging: Considerations and feasibility on clinical MRI and MRI-Linac.

Jokivuolle M, Mahmood F, Madsen K, Harbo F, Johnsen L, Lundell H Med Phys. 2024; 52(1):346-361.

PMID: 39387639 PMC: 11700005. DOI: 10.1002/mp.17453.


Multiparametric MRI for characterization of the tumour microenvironment.

Hoffmann E, Masthoff M, Kunz W, Seidensticker M, Bobe S, Gerwing M Nat Rev Clin Oncol. 2024; 21(6):428-448.

PMID: 38641651 DOI: 10.1038/s41571-024-00891-1.


Advances in the application of neuroinflammatory molecular imaging in brain malignancies.

Dong W, Wang N, Qi Z Front Immunol. 2023; 14:1211900.

PMID: 37533851 PMC: 10390727. DOI: 10.3389/fimmu.2023.1211900.


CEST2022: Amide proton transfer-weighted MRI improves the diagnostic performance of multiparametric non-contrast-enhanced MRI techniques in patients with post-treatment high-grade gliomas.

Huang Q, Wu J, Le N, Shen Y, Guo P, Schreck K Magn Reson Imaging. 2023; 102:222-228.

PMID: 37321378 PMC: 10528251. DOI: 10.1016/j.mri.2023.06.003.


Temporal Diffusion Ratio (TDR) for imaging restricted diffusion: Optimisation and pre-clinical demonstration.

Warner W, Palombo M, Cruz R, Callaghan R, Shemesh N, Jones D Neuroimage. 2023; 269:119930.

PMID: 36750150 PMC: 7615244. DOI: 10.1016/j.neuroimage.2023.119930.


References
1.
Welker K, Boxerman J, Kalnin A, Kaufmann T, Shiroishi M, Wintermark M . ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain. AJNR Am J Neuroradiol. 2015; 36(6):E41-51. PMC: 5074767. DOI: 10.3174/ajnr.A4341. View

2.
Valk P, Dillon W . Radiation injury of the brain. AJNR Am J Neuroradiol. 1991; 12(1):45-62. PMC: 8367566. View

3.
Barnholtz-Sloan J, Sloan A, Davis F, Vigneau F, Lai P, Sawaya R . Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 2004; 22(14):2865-72. DOI: 10.1200/JCO.2004.12.149. View

4.
Wu D, Jiang K, Li H, Zhang Z, Ba R, Zhang Y . Time-Dependent Diffusion MRI for Quantitative Microstructural Mapping of Prostate Cancer. Radiology. 2022; 303(3):578-587. DOI: 10.1148/radiol.211180. View

5.
Jiang X, Xu J, Gore J . Mapping hepatocyte size in vivo using temporal diffusion spectroscopy MRI. Magn Reson Med. 2020; 84(5):2671-2683. PMC: 7402009. DOI: 10.1002/mrm.28299. View